Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Risk Adjustment
Payers
Clover Health CEO Andrew Toy defends MA rate cut
CMS is not deviating from its January proposal to modestly rein in Medicare Advantage. Benchmark payments will still decrease 0.16%.
Noah Tong
Apr 3, 2024 11:00am
Alignment Healthcare to eliminate ACO REACH exposure
Feb 28, 2024 7:15am
Medicare Advantage fraud in DOJ's crosshairs
Feb 23, 2024 2:33pm
CMS proposes decline in 2025 Medicare Advantage payments
Jan 31, 2024 4:15pm
Editor's Corner—Fierce Health Payer's top 10 stories of 2023
Dec 22, 2023 6:00am
Texas court order blocks Bright Health claims enforcement
Dec 4, 2023 5:12pm